Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cangrelor As Treatment for Cardiac Surgery Associated With Heparin Induced Thrombocytopenia

NCT07817680 is registered in ClinicalTrials.gov with Société Française d'Anesthésie et de Réanimation as lead sponsor.

NCT NCT07817680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07817680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cangrelor As Treatment for Cardiac Surgery Associated With Heparin Induced Thrombocytopenia
Lead sponsor
Société Française d'Anesthésie et de Réanimation
Phase
Observational
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
February 1, 2028
Enrollment
132 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heparin-induced thrombocytopenia